Bakshi; Raman K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bakshi; Raman K..The latest application filed is for "acylated piperidine derivatives as melanocortin-4 receptor agonists".

Company Profile

0.13.10

Bakshi; Raman K. - Edison NJ
Bakshi, Raman K - Edison NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists App 20100160306 - Bakshi; Raman K. ; et al.	2010-06-24
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators Grant 7,652,024 - Bakshi , et al. January 26, 2	2010-01-26
Acylated Spiropiperidine Derivatives As Melanocortin-4 Receptor Modulators App 20090325990 - Bakshi; Raman K. ; et al.	2009-12-31
Acylated piperidine derivatives as melanocortin 4-receptor agonists Grant 7,618,987 - Bakshi , et al. November 17, 2	2009-11-17
Acylated piperidine derivatives as melanocortin-4 receptor modulators App 20090253744 - Bakshi; Raman K. ; et al.	2009-10-08
Acylated piperidine derivatives as melanocortin 4-receptor agonists App 20070191433 - Bakshi; Raman K. ; et al.	2007-08-16
Acylated piperazine derivatives as melanocortin-4 receptor agonists Grant 7,160,886 - Bakshi , et al. January 9, 2	2007-01-09
4-Azasteroids for treatment of hyperandrogenic conditions Grant RE39,056 - Bakshi , et al. April 4, 2	2006-04-04
Acylated piperidine derivatives as melanocortin-4 receptor agonists Grant 7,015,235 - Goulet , et al. March 21, 2	2006-03-21
Acylated piperidine derivatives as melanocortin-4 receptor agonists App 20060035935 - Goulet; Mark T. ; et al.	2006-02-16
Acylated piperazine derivatives as melanocortin-4 receptor agonists App 20040204398 - Bakshi, Raman K. ; et al.	2004-10-14
Substituted piperidines as melanocortin receptor agonists Grant 6,767,915 - Bakshi , et al. July 27, 2	2004-07-27
Acylated piperidine derivatives as melanocortin-4 receptor agonists App 20040097546 - Goulet, Mark T. ; et al.	2004-05-20
Substituted Piperidines As Melanocortin Receptor Agonists App 20030236262 - Bakshi, Raman K ; et al.	2003-12-25
Substituted piperidines as melanocortin-4 receptor agonists App 20020137664 - Bakshi, Raman K. ; et al.	2002-09-26
Spiropiperidine derivatives as melanocortin receptor agonists Grant 6,410,548 - Nargund , et al. June 25, 2	2002-06-25
Substituted piperidines as melanocortin-4 receptor agonists Grant 6,350,760 - Bakshi , et al. February 26, 2	2002-02-26
Spiropiperidine derivatives as melanocortin receptor agonists App 20010029259 - Nargund, Ravi P. ; et al.	2001-10-11
Spiropiperidine derivatives as melanocortin receptor agonists Grant 6,294,534 - Nargund , et al. September 25, 2	2001-09-25
4-Azasteroids for treatment of hyperandrogenic conditions Grant 6,001,844 - Bakshi , et al. December 14, 1	1999-12-14
4-oxa and 4-thia steriods Grant 5,777,134 - Bakshi , et al. July 7, 1	1998-07-07
17-Ethers and thioethers of 4-aza-steroids Grant 5,536,727 - Witzel , et al. July 16, 1	1996-07-16
Aryl ester derivatives of 3-oxo-4-aza-androstane 17-.beta.-carboxylates as 5-.alpha.-reductase inhibitors Grant 5,278,159 - Bakshi , et al. January 11, 1	1994-01-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.